The haemophilus ducreyi lspa1 protein inhibits phagocytosis by using a new mechanism involving Activation of C-terminal src kinase

mBio

Volumn 5, Issue 3, 2014, Pages

  Dodd, Dana A ^a   Worth, Randall G ^b   Rosen, Michael K ^a   Grinstein, Sergio ^c   van Oers, Nicolai S C ^a   Hansen, Eric J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; BACTERIAL PROTEIN; C TERMINAL SRC KINASE; CAGA PROTEIN; GLUTAMYLPROLYLISOLEUCYLTYROSYLGLYCINE; IMMUNOGLOBULIN G; PROTEIN LSPA1; PROTEIN TYROSINE KINASE; TYROSINE; UNCLASSIFIED DRUG; CSK TYROSINE-PROTEIN KINASE; LECTIN; LSPA1 PROTEIN, HAEMOPHILUS DUCREYI;

ANIMAL CELL; ARTICLE; BACTERIAL VIRULENCE; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PURIFICATION; HAEMOPHILUS DUCREYI; HUMAN; HUMAN CELL; MAMMAL CELL; MOUSE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; ANIMAL; CHEMISTRY; ENZYMOLOGY; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MICROBIOLOGY; PROTEIN TERTIARY STRUCTURE; ULCUS MOLLE;

ANIMALS; BACTERIAL PROTEINS; CHANCROID; ENZYME ACTIVATION; HAEMOPHILUS DUCREYI; HOST-PATHOGEN INTERACTIONS; HUMANS; LECTINS; PHAGOCYTOSIS; PROTEIN STRUCTURE, TERTIARY; SRC-FAMILY KINASES;

EID: 84903956934     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01178-14     Document Type: Article

References (47)

1. Al-Tawfiq JA, Spinola SM. 2002. Haemophilus ducreyi: clinical disease and pathogenesis. Curr. Opin. Infect. Dis. 15: 43-47. http://dx. doi. org/10. 1097/00001432-200202000-00008.
2. Bong CT, Bauer ME, Spinola SM. 2002. Haemophilus ducreyi: clinical features, epidemiology, and prospects for disease control. Microbes Infect. 4: 1141-1148. http://dx. doi. org/10. 1016/S1286-4579(02)01639-8.
3. Ronald AR, Albritton W. 1990. Chancroid and Haemophilus ducreyi, p 263-271. In Holmes KK, Mardh PA, Sparling PF, Wiesner PJ (ed), Sexually transmitted diseases, 2nd ed. McGraw-Hill, New York, NY.
4. Haydock AK, Martin DH, Morse SA, Cammarata C, Mertz KJ, Totten PA. 1999. Molecular characterization of Haemophilus ducreyi strains from Jackson, Mississippi and New Orleans, Louisiana. J. Infect. Dis. 179: 1423-1432. http://dx. doi. org/10. 1086/314771.
5. Spinola SM, Bauer ME, Munson RS, Jr. 2002. Immunopathogenesis of Haemophilus ducreyi infection (chancroid). Infect. Immun. 70: 1667-1676. http://dx. doi. org/10. 1128/IAI. 70. 4. 1667-1676. 2002.
6. Janowicz DM, Li W, Bauer ME. 2010. Host-pathogen interplay of Haemophilus ducreyi. Curr. Opin. Infect. Dis. 23: 64-69. http://dx. doi. org/10. 1097/QCO. 0b013e328334c0cb.
7. Janowicz DM, Ofner S, Katz BP, Spinola SM. 2009. Experimental infection of human volunteers with Haemophilus ducreyi: fifteen years of clinical data and experience. J. Infect. Dis. 199: 1671-1679. http://dx. doi. org/10. 1086/598966.
8. Janowicz DM, Fortney KR, Katz BP, Latimer JL, Deng K, Hansen EJ, Spinola SM. 2004. Expression of the LspA1 and LspA2 proteins by Haemophilus ducreyi is required for virulence in human volunteers. Infect. Immun. 72: 4528-4533. http://dx. doi. org/10. 1128/IAI. 72. 8. 4528-4533. 2004.
9. Ward CK, Lumbley SR, Latimer JL, Cope LD, Hansen EJ. 1998. Haemophilus ducreyi secretes a filamentous hemagglutinin-like protein. J. Bacteriol. 180: 6013-6022.
10. Ward CK, Mock JR, Hansen EJ. 2004. The LspB protein is involved in the secretion of the LspA1 and LspA2 proteins by Haemophilus ducreyi. Infect. Immun. 72: 1874-1884. http://dx. doi. org/10. 1128/IAI. 72. 4. 1874-1884. 2004.
11. Labandeira-Rey M, Mock JR, Hansen EJ. 2009. Regulation of expression of the Haemophilus ducreyi LspB and LspA2 proteins by CpxR. Infect. Immun. 77: 3402-3411. http://dx. doi. org/10. 1128/IAI. 00292-09.
12. Vakevainen M, Greenberg S, Hansen EJ. 2003. Inhibition of phagocytosis by Haemophilus ducreyi requires expression of the LspA1 and LspA2 proteins. Infect. Immun. 71: 5994-6003. http://dx. doi. org/10. 1128/IAI. 71. 10. 5994-6003. 2003.
13. Mock JR, Vakevainen M, Deng K, Latimer JL, Young JA, van Oers NS, Greenberg S, Hansen EJ. 2005. Haemophilus ducreyi targets Src family protein tyrosine kinases to inhibit phagocytic signaling. Infect. Immun. 73: 7808-7816. http://dx. doi. org/10. 1128/IAI. 73. 12. 7808-7816. 2005.
14. Flannagan RS, Jaumouillé V, Grinstein S. 2012. The cell biology of phagocytosis. Annu. Rev. Pathol. 7: 61-98. http://dx. doi. org/10. 1146/annurev-pathol-011811-132445.
15. Berton G, Mócsai A, Lowell CA. 2005. Src and Syk kinases: key regulators of phagocytic cell activation. Trends Immunol. 26: 208-214. http://dx. doi. org/10. 1016/j. it. 2005. 02. 002.
16. Fitzer-Attas CJ, Lowry M, Crowley MT, Finn AJ, Meng F, DeFranco AL, Lowell CA. 2000. Fcgamma receptor-mediated phagocytosis in macrophages lacking the Src family tyrosine kinases Hck, Fgr, and Lyn. J. Exp. Med. 191: 669-682. http://dx. doi. org/10. 1084/jem. 191. 4. 669.
17. Lowell CA. 2004. Src-family kinases: rheostats of immune cell signaling. Mol. Immunol. 41: 631-643. http://dx. doi. org/10. 1016/j. molimm. 2004. 04. 010.
18. Resh MD. 1994. Myristylation and palmitylation of Src family members: the fats of the matter. Cell 76: 411-413. http://dx. doi. org/10. 1016/0092-8674(94)90104-X.
19. Roskoski R, Jr. 2004. Src protein-tyrosine kinase structure and regulation. Biochem. Biophys. Res. Commun. 324: 1155-1164. http://dx. doi. org/10. 1016/j. bbrc. 2004. 09. 171.
20. Bjorge JD, Jakymiw A, Fujita DJ. 2000. Selected glimpses into the activation and function of Src kinase. Oncogene 19: 5620-5635. http://dx. doi. org/10. 1038/sj. onc. 1203923.
21. Frame MC. 2002. Src in cancer: deregulation and consequences for cell behaviour. Biochim. Biophys. Acta 1602: 114-130. http://dx. doi. org/10. 1016/S0304-419X(02)00040-9.
22. Roskoski R, Jr. 2005. Src kinase regulation by phosphorylation and dephosphorylation. Biochem. Biophys. Res. Commun. 331: 1-14. http://dx. doi. org/10. 1016/j. bbrc. 2005. 03. 012.
23. Okada M. 2012. Regulation of the SRC family kinases by Csk. Int. J. Biol. Sci. 8: 1385-1397. http://dx. doi. org/10. 7150/ijbs. 5141.
24. Ogawa A, Takayama Y, Sakai H, Chong KT, Takeuchi S, Nakagawa A, Nada S, Okada M, Tsukihara T. 2002. Structure of the carboxyl-terminal Src kinase, Csk. J. Biol. Chem. 277: 14351-14354. http://dx. doi. org/10. 1074/jbc. C200086200.
25. Wong L, Lieser SA, Miyashita O, Miller M, Tasken K, Onuchic JN, Adams JA, Woods VL, Jr, Jennings PA. 2005. Coupled motions in the SH2 and kinase domains of Csk control Src phosphorylation. J. Mol. Biol. 351: 131-143. http://dx. doi. org/10. 1016/j. jmb. 2005. 05. 042.
26. Suzuki T, Kono H, Hirose N, Okada M, Yamamoto T, Yamamoto K, Honda Z. 2000. Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis. J. Immunol. 165: 473-482. http://dx. doi. org/10. 4049/jimmunol. 165. 1. 473.
27. Sarantis H, Grinstein S. 2012. Subversion of phagocytosis for pathogen survival. Cell Host Microbe 12: 419-431. http://dx. doi. org/10. 1016/j. chom. 2012. 09. 001.
28. Deng K, Mock JR, Greenberg S, van Oers NS, Hansen EJ. 2008. Haemophilus ducreyi LspA proteins are tyrosine phosphorylated by macrophage-encoded protein tyrosine kinases. Infect. Immun. 76: 4692-4702. http://dx. doi. org/10. 1128/IAI. 00513-08.
29. Hayashi T, Morohashi H, Hatakeyama M. 2013. Bacterial EPIYA effectors-where do they come from? What are they? Where are they going? Cell. Microbiol. 15: 377-385. http://dx. doi. org/10. 1111/cmi. 12040.
30. Backert S, Selbach M. 2005. Tyrosine-phosphorylated bacterial effector proteins: the enemies within. Trends Microbiol. 13: 476-484. http://dx. doi. org/10. 1016/j. tim. 2005. 08. 002.
31. Selbach M, Paul FE, Brandt S, Guye P, Daumke O, Backert S, Dehio C, Mann M. 2009. Host cell interactome of tyrosine-phosphorylated bacterial proteins. Cell. Host Microbe 5: 397-403. http://dx. doi. org/10. 1016/j. chom. 2009. 03. 004.
32. Safari F, Murata-Kamiya N, Saito Y, Hatakeyama M. 2011. Mammalian Pragmin regulates Src family kinases via the Glu-Pro-Ile-Tyr-Ala (EPIYA) motif that is exploited by bacterial effectors. Proc. Natl. Acad. Sci. U. S. A. 108: 14938-14943. http://dx. doi. org/10. 1073/pnas. 1107740108.
33. Tollis S, Dart AE, Tzircotis G, Endres RG. 2010. The zipper mechanism in phagocytosis: energetic requirements and variability in phagocytic cup shape. BMCSyst. Biol. 4: 149. http://dx. doi. org/10. 1186/1752-0509-4-149.
34. Backert S, Moese S, Selbach M, Brinkmann V, Meyer TF. 2001. Phosphorylation of tyrosine 972 of the Helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Mol. Microbiol. 42: 631-644.
35. Hatakeyama M, Higashi H. 2005. Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis. Cancer Sci. 96: 835-843. http://dx. doi. org/10. 1111/j. 1349-7006. 2005. 00130. x.
36. Wood GE, Dutro SM, Totten PA. 2001. Haemophilus ducreyi inhibits phagocytosis by U-937 cells, a human macrophage-like cell line. Infect. Immun. 69: 4726-4733. http://dx. doi. org/10. 1128/IAI. 69. 8. 4726-4733. 2001.
37. Ahmed HJ, Johansson C, Svensson LA, Ahlman K, Verdrengh M, Lagergård T. 2002. In vitro and in vivo interactions of Haemophilus ducreyi with host phagocytes. Infect. Immun. 70: 899-908. http://dx. doi. org/10. 1128/IAI. 70. 2. 899-908. 2002.
38. Hansen EJ, Latimer JL, Thomas SE, Helminen M, Albritton WL, Radolf JD. 1992. Use of electroporation to construct isogenic mutants of Haemophilus ducreyi. J. Bacteriol. 174: 5442-5449.
39. Spinola SM, Fortney KR, Baker B, Janowicz DM, Zwickl B, Katz BP, Blick RJ, Munson RS, Jr. 2010. Activation of the CpxRA system by deletion of cpxA impairs the ability of Haemophilus ducreyi to infect humans. Infect. Immun. 78: 3898-3904. http://dx. doi. org/10. 1128/IAI. 00432-10.
40. Levinson NM, Seeliger MA, Cole PA, Kuriyan J. 2008. Structural basis for the recognition of c-Src by its inactivator Csk. Cell 134: 124-134. http://dx. doi. org/10. 1016/j. cell. 2008. 05. 051.
41. Bain J, McLauchlan H, Elliott M, Cohen P. 2003. The specificities of protein kinase inhibitors: an update. Biochem. J. 371: 199-204. http://dx. doi. org/10. 1042/BJ20021535.
42. Egerer M, Satchell KJ. 2010. Inositol hexakisphosphate-induced autoprocessing of large bacterial protein toxins. PLoS Pathog. 6: e1000942. http://dx. doi. org/10. 1371/journal. ppat. 1000942.
43. Satchell KJ. 2007. MARTX, multifunctional autoprocessing repeats-intoxin toxins. Infect. Immun. 75: 5079-5084. http://dx. doi. org/10. 1128/IAI. 00525-07.
44. Worth RG, Kim MK, Kindzelskii AL, Petty HR, Schreiber AD. 2003. Signal sequence within Fc gamma RIIA controls calcium wave propagation patterns: apparent role in phagolysosome fusion. Proc. Natl. Acad. Sci. U. S. A. 100: 4533-4538. http://dx. doi. org/10. 1073/pnas. 0836650100.
45. Vieth JA, Kim MK, Glaser D, Stiles K, Schreiber AD, Worth RG. 2013. FcgammaRIIa requires lipid rafts, but not co-localization into rafts, for effector function. Inflamm. Res. 62: 37-43. http://dx. doi. org/10. 1007/s00011-012-0548-1.
46. Cox J, Mann M. 2008. MaxQuant enables high peptide identification rates, individualized p. p. b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26: 1367-1372. http://dx. doi. org/10. 1038/nbt. 1511.
47. UniProt Consortium. 2012. Reorganizing the protein space at the Universal Protein Resource (UniProt). Nucleic Acids Res. 40: D71-D75. http://dx. doi. org/10. 1093/nar/gkr981. PubMed.